Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 5:57 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 169–192 of 222 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Emotional Sensitivity test Clear all

Conditions: Acute Kidney Injury
Interventions: Not listed
Lead sponsor: Adam C Dziorny; Other
Eligibility: 30 Days to 18 Years
Enrollment: 800 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Affective Symptoms, Empathy
Interventions: Facial Affect Sensitivity Training (FAST), Implicit Gaze Training task (Active control condition); Behavioral
Lead sponsor: University of Alabama, Tuscaloosa; Other
Eligibility: 6 Years to 11 Years
Enrollment: 161 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Tuscaloosa, Alabama

Conditions: Healthy Donors, HIV Positive
Interventions: collection of follow-up sample based on PRISM HIV O Plus result; Device
Lead sponsor: Abbott Diagnostics Division; Industry
Eligibility: 17 Years and older
Enrollment: 24,111 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 7
States / cities: Davenport, Iowa • Kansas City, Missouri • Dayton, Ohio + 4 more

Conditions: Metabolic Syndrome
Interventions: muscle biopsy; Procedure
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 65 Years
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2024
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Obesity, Insulin Resistance
Interventions: Fat biopsy during scheduled abdominal surgery, Fat Aspiration, Fish Oil Supplement; Procedure · Dietary Supplement
Lead sponsor: Mayo Clinic; Other
Eligibility: 30 Years to 50 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: Scottsdale, Arizona

Conditions: Non-small Cell Lung Cancer, Recurrent Non-Small Cell Lung Carcinoma
Interventions: Yoga, Support Group Therapy, FACT-L, Pulmonary function test; Behavioral · Other
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: Not listed
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Gastroesophageal Reflux Disease, Chronic Cough, Broncho-hyperreactivity
Interventions: Cough Reflex Sensitivity, Methacholine Challenge; Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 60 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Stress Disorders, Post-Traumatic
Interventions: Microneurography, Combat virtual reality video clip, Handgrip Exercise, Cold Pressor Test (CPT), Sodium Nitroprusside (SNP), Phenylephrine, Losartan, Atenolol, Transcutaneous Vagal Nerve Stimulation (tVNS), Sham Transcutaneous Vagal Nerve Stimulation (tVNS); Procedure · Behavioral · Drug + 1 more
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 134 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2027
U.S. locations: 1
States / cities: Decatur, Georgia

Conditions: Kidney Transplantation
Interventions: NA-Observational only; Other
Lead sponsor: Biohope Scientific Solutions for Human Health, S.L.; Industry
Eligibility: 25 Years to 69 Years
Enrollment: 164 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hypertension, Menopause, Premature, Menopause, Blood Pressure
Interventions: Microneurography to measure muscle sympathetic nerve activity (MSNA), Baroreflex sensitivity testing, Sympathoexcitatory Maneuvers, Blood tests; Diagnostic Test
Lead sponsor: University of Minnesota; Other
Eligibility: 35 Years to 70 Years · Female only
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Cow's Milk Allergy
Interventions: DBV1605; Combination Product
Lead sponsor: DBV Technologies; Industry
Eligibility: 29 Days to 24 Months
Enrollment: 230 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 20
States / cities: Phoenix, Arizona • Tucson, Arizona • San Diego, California + 16 more

Conditions: Rheumatoid Arthritis
Interventions: Tc 99m tilmanocept; Drug
Lead sponsor: Navidea Biopharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 116 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 10
States / cities: Scottsdale, Arizona • Los Angeles, California • San Francisco, California + 7 more

Conditions: Barrett Esophagus, GERD, Obesity, Esophageal Cancer
Interventions: Esocheck/Esoguard; Diagnostic Test
Lead sponsor: Louis Stokes VA Medical Center; Federal
Eligibility: 40 Years to 85 Years
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Obesity, Morbid, Ventilator-Induced Lung Injury, Respiratory Failure
Interventions: Esophageal balloon, Intervention Spontaneous Breathing Trial (SBT) and Extubation, Control Spontaneous Breathing Trial and Extubation, Intervention Weaning after Tracheostomy, Control Weaning after Tracheostomy; Device · Procedure
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 2
States / cities: Chapel Hill, North Carolina • Greenville, North Carolina

Conditions: Age-Related Macular Degeneration, Geographic Atrophy
Interventions: Optical coherence tomography, Microperimetry; Diagnostic Test
Lead sponsor: University of California, San Francisco; Other
Eligibility: 55 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: ACTINIC KERATOSIS
Interventions: Ingenol Mebutate (Picato®), Generic Ingenol Mebutate, Vehicle Foam; Drug
Lead sponsor: Actavis Inc.; Industry
Eligibility: 18 Years to 95 Years
Enrollment: 507 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 23
States / cities: Oceanside, California • Denver, Colorado • Aventura, Florida + 20 more

Conditions: Type 2 Diabetes
Interventions: Vitamin D3, Omega-3 fatty acid (fish oil), Vitamin D3 placebo, Fish oil placebo; Dietary Supplement · Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 50 Years and older
Enrollment: 22,220 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Dentin Sensitivity
Interventions: Mouth Rinse, Fluoride Toothpaste, Potassium Nitrate Toothpaste; Device · Drug
Lead sponsor: Johnson & Johnson Consumer and Personal Products Worldwide; Industry
Eligibility: 18 Years and older
Enrollment: 153 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Cancer, Predictive Cancer Model, Effects of Chemotherapy
Interventions: Known 3Dx Test; Diagnostic Test
Lead sponsor: Known Medicine, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 2,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 3
States / cities: Rochester, Minnesota • Durham, North Carolina • Houston, Texas

Conditions: Syphilis Infection
Interventions: Rapid Syphilis Test; Diagnostic Test
Lead sponsor: Queen's Medical Center; Other
Eligibility: 14 Years and older · Female only
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Honolulu, Hawaii

Conditions: Allergy, Hypersensitivity, Immediate, Ig-E Mediated Food
Interventions: AllerTest-10 Multi-Head Skin Test Device, Skintestor OMNI Multi-Head Skin Test Device, Multi-Test II Multi-Head Skin Test Device, AllerTest-8 Multi-Head Skin Test Device; Device
Lead sponsor: QHSLab, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Obesity, Healthy
Interventions: PET Scan, Mixed Meal Test, Muscle sympathetic nerve activity (MSNA), Oral Glucose Tolerance Test, Body Composition, Percent Body Fat & Percent Body Water (Tanita scale), CT Scan, Body Composition, Percent Body Fat & Percent Body Water (DXA Scan); Diagnostic Test · Dietary Supplement · Other
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 45 Years
Enrollment: 5 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Shift Work Schedule, Circadian Rhythm, Insulin Resistance, Circadian Misalignment
Interventions: Metyrapone And Hydrocortisone, Dextrose, insulin; Drug
Lead sponsor: Washington State University; Other
Eligibility: 18 Years to 45 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Spokane, Washington

Conditions: Alzheimer Disease
Interventions: Blood draws, Hyperinsulinemic Euglycemic Clamp Technique Insulin Sensitivity test, Resting Metabolic Rate (RMR); Other
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 65 Years to 75 Years · Male only
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Search by objective public record fields.

Prospective Validation of AKI Prediction

Facial Affect Sensitivity Training for Young Children With Callous-unemotional Traits

Evaluation of a Human Immunodeficiency Virus (HIV) Blood Screening Assay

Composition & Function of Sarcoplasmic Reticulum in Persons With the Metabolic Syndrome

Understanding the Relationship Between Inflammation and Insulin Resistance in the Adipose Tissue

Yoga in Improving Quality of Life in Patients With Non-small Cell Lung Cancer Undergoing Treatment

Cough Reflex Sensitivity and Bronchial Hyper-responsiveness

Role of Sympathetic Overactivity and Angiotensin II in PTSD and CV

Evaluation of Immunobiogram® as a Tool in Adjustment of Immunosuppressant Therapy for Renal Transplant

Autonomic Regulation of Blood Pressure in Premature and Early Menopausal Women

Diagnostic Accuracy and Safety of DBV1605 for the Diagnosis of Non-IgE Mediated Cow's Milk Allergy in Children

Evaluation of the Precision and Sensitivity of Tilmanocept Uptake Value (TUV) on Tc 99m Tilmanocept Planar Imaging

Non-endoscopic Esophageal Sampling to Detect Barrett's Esophagus and Esophageal Cancer in Veterans

Providing Optimal PEEP During Mechanical Ventilation for Obese Patients Using Esophageal Balloon

Central micrOperimetry and Radial OCT Evaluation in Geographic Atrophy (CORE-GA): a Prospective Pilot Study

An Equivalence Study of Generic Ingenol Mebutate Gel 0.015% and Picato Gel 0.015% in Subjects With Actinic Keratosis

Study of Vitamin D and Omega-3 Supplementation for Preventing Diabetes

A Test on a New Experimental Mouth Rinse for Relieving Tooth Sensitivity

KM3D Multicenter Cancer Consortium: Predicting Patient Response Using 3D Cell Culture Models

Feasibility and Acceptability of Point of Care Rapid Syphilis Testing Among Patients Seeking Family Planning Services in Hawai'i

Head-to-Head Comparison Study Between Different FDA Registered Allergy Skin Test Applicators

Sympathetic Activation in Obesity

Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance

Effect of Physiologic Insulin Administration on Cognition